Recently, a phenomenon of multiple (usually two) co-occurring PIK3CA mutations was described in breast cancer and other tumor types: these mutations occur mainly in cis, are mutually exclusive with other driver genetic alterations, and confer increased sensitivity to PI3K inhibition [22,23]. Here, PIK3CA is linked to neoplasm.